Health BioNTech Settles mRNA Patent Dispute, Gains New Financial Backing BioNTech has reached a settlement in a three-year patent dispute involving mRNA technology with GlaxoSmithKline (GSK) and CureVac. As part of this agreement, both... Editorial12 hours ago